VERTEX PHARMACEUTICALS INC / MA

VRTX

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0000875320-26-000134
Filing date: Mar 4, 2026
Earliest execution date: Mar 2, 2026
Reporting Owners: Liu Joy (EVP and Chief Legal Officer)
SEC Filing link

Summary

Type

Sell

Net shares

-892

% of shares

-3.76%

Amount (USD)

$442,396

Insider confidence score

37.5 out of 100

Positive

  • Under Rule 10b5-1 trading plan

Negative

  • Significant scheduled sell (<5% of shares)
  • Large sell amount ($250K+)

Stock transactions

Transaction 1

Security

Common Stock

Action

Sell

Date

2026-03-02

Code

S

Net shares

-892.0

Price per Share

$495.96

Amount (USD)

$442,396.32

Acquired/Disposed

Disposed

Shares Owned Before

23,703.0

Shares Owned After

22,811.0

Filing's footnotes

1. Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025.

ℹ️ Filed under Rule 10b5-1 trading plan

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.